Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Sutab"

2 News Found

Lupin secures FDA nod for generic Sutab tablets with 180-day exclusivity
Drug Approval | May 30, 2026

Lupin secures FDA nod for generic Sutab tablets with 180-day exclusivity

The approved product is the generic equivalent of Sutab® Tablets developed by Azurity Pharmaceuticals

Lupin wins FDA nod for generic colonoscopy prep drug with first-to-file exclusivity
Drug Approval | May 30, 2026

Lupin wins FDA nod for generic colonoscopy prep drug with first-to-file exclusivity

Crucially, Lupin is the exclusive first-to-file applicant for this product and is eligible for 180-day generic drug exclusivity in the U.S. market

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial

Merck’s experimental cancer drug wins FDA breakthrough status in key lung cancer setting

Glenmark posts strong FY26 results with 27.5% revenue jump

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India
Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India
Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences
Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences
Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India
Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India

Packaging